We are live on ! Find out more
ECM

Endurant Capital Management Portfolio holdings

AUM $17.4M
1-Year Est. Return 7.38%
This Fund
S&P 500
This Quarter Est. Return
+5.47%
1 Year Est. Return
+7.38%
3 Year Est. Return
+18.38%
5 Year Est. Return
+100.61%
10 Year Est. Return
–
AUM
$299M
AUM Growth
-$9.51M
Cap. Flow
-$30.5M
Cap. Flow %
-10.19%
Top 10 Hldgs %
42.64%
Holding
104
New
18
Increased
30
Reduced
39
Closed
16

Top Buys

Rank Stock Value
1
ABT icon
Abbott
ABT
+$11.4M
2
AGN
Allergan plc
AGN
+$10.5M
3
WMGI
Wright Medical Group Inc
WMGI
+$8.41M
4
SHPG
Shire pic
SHPG
+$6.98M
5
MCK icon
McKesson
MCK
+$4.79M

Top Sells

Rank Stock Value
1
HRC
HILL-ROM HOLDINGS, INC.
HRC
+$8.16M
2
EVHC
Envision Healthcare Holdings Inc
EVHC
+$7.43M
3
ZBH icon
Zimmer Biomet
ZBH
+$7.17M
4
BXLT
BAXALTA INC COM STK (DE)
BXLT
+$7.08M
5
MDT icon
Medtronic
MDT
+$5.39M

Sector Composition

Rank Sector Weight
1 Healthcare 88.92%
2 Financials 3.84%
3 Industrials 1.57%
4 Energy 1.04%
5 Technology 0.1%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PFE icon
51
Pfizer
PFE
$143B
$1.13M 0.38%
33,833
-113,411
-77% -$3.62M
CVS icon
52
CVS Health
CVS
$133B
$1.09M 0.36%
11,385
+2,885
+34% +$288K
HCA icon
53
HCA Healthcare
HCA
$87.2B
$1.07M 0.36%
13,911
-68,269
-83% -$5.39M
PEN icon
54
Penumbra
PEN
$12.7B
$1.01M 0.34%
16,900
-7,800
-32% -$420K
HZNP
55
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$930K 0.31%
56,440
-42,400
-43% -$686K
CTLT
56
DELISTED
CATALENT, INC.
CTLT
$929K 0.31%
+40,400
New +$1.07M
BAX icon
57
Baxter International
BAX
$13.5B
$900K 0.3%
+19,909
New +$873K
WAT icon
58
Waters Corp
WAT
$37B
$872K 0.29%
+6,200
New +$839K
GI
59
DELISTED
EndoChoice Holdings, Inc.
GI
$829K 0.28%
169,163
+38,400
+29% +$183K
SSRG
60
DELISTED
SYMMETRY SURGICAL INC COMMON STK
SSRG
$812K 0.27%
61,819
+14,500
+31% +$175K
BHC icon
61
Bausch Health
BHC
$2.58B
$808K 0.27%
40,100
+26,600
+197% +$753K
AMPH icon
62
Amphastar Pharmaceuticals
AMPH
$879M
$787K 0.26%
48,825
-91,325
-65% -$1.29M
DERM
63
DELISTED
Dermira, Inc.
DERM
$766K 0.26%
26,188
+13,000
+99% +$359K
PARN
64
DELISTED
Parnell Pharmaceuticals Holdings Ltd
PARN
$732K 0.24%
448,802
+62,900
+16% +$116K
LUMO
65
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
$704K 0.24%
+6,943
New +$861K
TVTY
66
DELISTED
Tivity Health, Inc. Common Stock
TVTY
$693K 0.23%
60,016
+8,805
+17% +$103K
PRGO icon
67
Perrigo
PRGO
$1.4B
$689K 0.23%
7,600
+4,000
+111% +$414K
INCY icon
68
Incyte
INCY
$24.2B
$664K 0.22%
8,300
+500
+6% +$38.8K
NBIX icon
69
Neurocrine Biosciences
NBIX
$16.8B
$641K 0.21%
14,100
+1,000
+8% +$46K
AERI
70
DELISTED
Aerie Pharmaceuticals
AERI
$588K 0.2%
33,400
-9,800
-23% -$159K
ILMN icon
71
Illumina
ILMN
$31B
$543K 0.18%
3,978
-7,638
-66% -$1.09M
VRTX icon
72
Vertex Pharmaceuticals
VRTX
$121B
$538K 0.18%
6,250
-2,500
-29% -$216K
CI icon
73
Cigna
CI
$73.7B
$523K 0.17%
4,089
+2,223
+119% +$293K
RAD
74
DELISTED
Rite Aid Corporation
RAD
$454K 0.15%
3,030
-3,075
-50% -$485K
MTD icon
75
Mettler-Toledo International
MTD
$28.6B
$401K 0.13%
+1,100
New +$402K
1 2
3
4 5

Similar funds

VAFP
Vahanian & Associates Financial Planning Saratoga Springs, New York $25.3M AUM 39.42% 1-Year Est. Return
CA
Corriente Advisors Fort Worth, Texas $9.53M AUM 805.26% 1-Year Est. Return
SCM
Somerset Capital Management London, United Kingdom $8.12M AUM 21.3% 1-Year Est. Return
FWM
Fiat Wealth Management Wayzata, Minnesota $7.9M AUM
TOPU
Trustees of Princeton University Princeton, New Jersey $7.77M AUM
CCMU
Cheyne Capital Management (UK) London, United Kingdom $27.9M AUM 36.14% 1-Year Est. Return
TGI
TRV GP III Boston, Massachusetts $6.14M AUM 45.44% 1-Year Est. Return
HSCU
Half Sky Capital (UK) London, United Kingdom $30.5M AUM 67.32% 1-Year Est. Return

Endurant Capital Management's Q2 2016 Portfolio in Review

As of Q2 2016, Endurant Capital Management held 104 positions worth $299M, down 3.1% from $309M the previous quarter. Its ten largest holdings account for 43% of the portfolio.

Endurant Capital Management withdrew a net $30.5M in Q2 2016, closing 16 positions and reducing 39 holdings. Its most notable exit was BAXALTA INC COM STK (DE), an estimated $7.08M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 89% of assets, up from 84% a quarter earlier, followed by Financials and Industrials.

Against the trend, Endurant Capital Management opened a new position in Cencora worth $3.85M.

  • Endurant Capital Management's largest Q2 2016 buy was Cencora: 48,600 shares worth $3.85M.
  • Endurant Capital Management added most to Abbott in Q2 2016, an estimated $11.4M increase.
  • Endurant Capital Management's biggest Q2 2016 reduction was HILL-ROM HOLDINGS, INC., cutting an estimated $8.16M.
  • Endurant Capital Management fully exited BAXALTA INC COM STK (DE) in Q2 2016, selling an estimated $7.08M.
  • Endurant Capital Management's ten largest holdings make up 43% of its $299M portfolio in Q2 2016.
  • Endurant Capital Management opened 18 new positions and closed 16 in Q2 2016.
  • Endurant Capital Management's portfolio value fell 3.1% quarter-over-quarter to $299M.

Based on Endurant Capital Management's 13F filing for Q2 2016, filed 15 Aug 2016.